Earnings and Results
Operating costs fell and the company benefited from a deferred income tax credit.
1
Grab's Singapore e-wallet GrabPay reports higher profit in 2025
2
Vietnam tech giant FPT bets on rising AI demand in Thailand
3
Hong Kong eases listing thresholds to draw more IPOs
4
AI shortens drug discovery to around 1 year in China, Insilico CEO says
5
China to tax offshore trusts as Beijing targets overseas wealth
More Stories
Singapore’s Monk’s Hill undergoes restructuring, strategy shift
Allianz to acquire HSBC’s Singapore insurance business in $2b deal
NIIF invests $15m in specialty healthcare chain NU Hospitals
CXMT to list in Shanghai on July 27 after Asia’s biggest IPO this year
ADM Capital raises $48m for climate finance in Indonesia
Analysis
The company is building partnerships with leading businesses, university.
Policy & Regulations
The steps are part of a wider push by Hong Kong to strengthen its position as a fundraising hub.
Interviews
This gives it an edge over traditional Western pharmaceutical giants.
The rules feature sweeping anti-avoidance provisions.
Greater China
Reuters earlier reported that AgiBot appointed banks in October.
Singapore
Finnomena will offer up to 30,000,838 shares, or 15% of its issued and paid-up shares after the offering.
Besides Singapore’s ST Engineering, Temasek has never really looked at defence.
India
The move follows the exit of a Rs 950-crore investment in a global agrochemicals platform.
Last month, HCLTech acquired a 10.5% stake in Sarvam AI for $150m.
